Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect
OwnerJohn G. Babish, Terrence Howellinventors
Life of this patent
Estimating the term…
Abstract
A novel formulation is provided that serves to synergistically inhibit the generation of free radicals and oxidative stress in warm blooded animals. The formulation comprises an effective amount of a first component of a carotenoid species, and, as a second component, a tocotrienol species and derivatives thereof, and provides for synergistic anti-oxidant activity.
Claims40
A composition having synergistic antioxidant activity comprising an effective amount of a first component of a carotenoid species, and, as a second component, a tocotrienol species or derivatives thereof.
A composition having synergistic antioxidant activity comprising an effective amount of a first component of a carotenoid species selected from the group consisting of astaxanthin, alpha-carotene, beta-carotene, lutein, lycopene, zeaxanthin, phytoene, fucoxanthin, peridin and cantaxanthin;
- and as a second component, a tocotrienol species selected from the group consisting of tocotrienol, alpha-, beta-, gamma-, delta-tocotrienol, desmethyl-tocotrienol, didesmethyl-tocotrienol and mixtures thereof
A composition having synergistic antioxidant activity comprising an effective amount of a first component of a carotenoid species selected from the group consisting of astaxanthin, beta-carotene, lutein and lycopene;
- and as a second component, a tocotrienol species selected from the group of tocotrienol, alpha-, beta-, gamma-, delta-tocotrienol and mixtures thereof.
A composition having synergistic antioxidant activity comprising an effective amount of a first component of a pharmaceutical grade carotenoid species selected from the group consisting of astaxanthin, beta-carotene, lutein and lycopene;
- and as a second component, a pharmaceutical grade tocotrienol species selected from the group of tocotrienol, alpha-, beta-, gamma-, delta-tocotrienol and mixtures thereof.
A composition having synergistic antioxidant activity comprising an effective amount of a first component of a pharmaceutical grade carotenoid species selected from the group consisting of astaxanthin, beta-carotene, lutein and lycopene;
- and as a second component, a mixture of alpha- and beta-tocotrienol or a mixture of alpha-, beta-, gamma- and delta-tocotrienol.
A composition having synergistic antioxidant activity comprising an effective amount of a first component of a pharmaceutical grade carotenoid species selected from the group consisting of astaxanthin, beta-carotene, lutein and lycopene;
- and as a second component, a mixture of alpha-, beta-, gamma- and delta-tocotrienol.
A method for normalization and therapeutic treatment of symptoms of oxidative stress in warm blooded animals comprising administering to an animal a composition comprising an effective amount of a first component of a carotenoid species, and as a second component, a tocotrienol species and derivatives thereof;
- and continuing said administration until said symptoms of oxidative stress are reduced.
A method for normalization and therapeutic treatment of symptoms of oxidative stress in warm blooded animals comprising administering to an animal a composition comprising an effective amount of a first component of a carotenoid species selected from the group consisting of astaxanthin, alpha-carotene, beta-carotene, lutein, lycopene, zeaxanthin, phytoene, fucoxanthin, peridin and cantaxanthin;
- and as a second component, a tocotrienol species selected from the group consisting of tocotrienol, alpha-, beta-, gamma-, delta-tocotrienol, desmethyl-tocotrienol, didesmethyl-tocotrienol and mixtures thereof;
- and continuing said administration until said symptoms of oxidative stress are reduced.
A method for normalization and therapeutic treatment of symptoms of oxidative stress in warm blooded animals comprising administering to an animal a composition comprising an effective amount of a first component of a carotenoid species selected from the group consisting of astaxanthin, beta-carotene, lutein and lycopene;
- and as a second component, a tocotrienol species selected from the group of tocotrienol, alpha-, beta-, gamma-, delta-tocotrienol and mixtures thereof;
- and continuing said administration until said symptoms of oxidative stress are reduced.
A method for normalization and therapeutic treatment of symptoms of oxidative stress in warm blooded animals comprising administering to an animal a composition comprising an effective amount of a first component of a pharmaceutical grade carotenoid species selected from the group consisting of astaxanthin, beta-carotene, lutein and lycopene;
- and as a second component, a pharmaceutical grade tocotrienol species selected from the group of tocotrienol, alpha-, beta-, gamma-, delta-tocotrienol and mixtures thereof;
- and continuing said administration until said symptoms of oxidative stress are reduced.
Dependencies are inferred from the claim text.